Market Currents
Hyperion Therapeutics (HPTX -1.2%) names Daniel G. Welch to its Board of Directors. Mr. Welch...
-
Tuesday, August 28, 2012, 4:10 PM ETHyperion Therapeutics (HPTX -1.2%) names Daniel G. Welch to its Board of Directors. Mr. Welch currently serves as Chairman, CEO and President of InterMune (ITMN +1%). Mr. Welch brings more than 30 years of experience in the biotechnology and pharmaceutical industries.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment:
what does this do for ITMN?